Following their Senate Finance Committee hearing in February, all seven biopharmaceutical CEOs have now offered hundreds of pages of written responses to more specific questions. The lackluster ...

Gearing up for the prospect of the UK departing from the EU without a deal, biopharma companies are preparing with different precautions costing upward of $100 million per company. Novartis on Friday ...

Are you interested in working in the biopharma industry, or simply looking to better understand this important sector of health care? This article will outline what biopharma is, how it is changing ...

The potential of companies developing artificial intelligence (AI)-based tools for drug discovery and development has driven investment and deals with major biopharma companies, but challenges for AI ...

Biopharma is reshaping the healthcare industry, and smart investors are paying close attention. The healthcare sector could see major changes as artificial intelligence accelerates drug discovery, ...

Biopharma companies face unique challenges in scaling AI-and those challenges vary greatly depending on whether you’re at a small or large biopharma. While large biopharma is pushing ahead with nearly ...

Bioprocessing 4.0 is a reality. It is part of a broader movement known as Industry 4.0, which is, essentially, the fourth industrial revolution. The idea of the fourth industrial revolution was ...

Symbolic milestone for new buffer media station: Rentschler Biopharma underscores its commitment to the Laupheim headquarters and to the future of Germany and Europe as leading biotechnology hubs ...